Gabapentin is FDA-approved to treat postherpetic neuralgia, the nerve pain that lingers after a shingles rash has healed. It is not approved for treating pain during the active shingles outbreak itself, and clinical trials have found it provides no significant benefit during that acute phase. The distinction matters because most people searching this question are either dealing with an active rash or living with persistent pain weeks or months later, and gabapentin’s usefulness depends entirely on which situation you’re in.
Active Shingles vs. Postherpetic Neuralgia
Shingles causes two different kinds of pain, and they require different treatments. The first is acute pain that comes with the blistering rash, typically lasting two to four weeks. The second is postherpetic neuralgia (PHN), a deeper nerve pain that persists after the rash clears. PHN can last months or even years and affects roughly 10 to 18 percent of people who get shingles, with the risk climbing sharply after age 60.
Gabapentin targets the second kind. It works on damaged nerve signaling, which is why it helps once the virus has already done its damage to nerve fibers but offers little during the active infection itself. For the acute rash phase, antiviral medications are the primary treatment, ideally started within 72 hours of the rash appearing.
Why Gabapentin Doesn’t Help During the Rash
A double-blind, randomized controlled trial tested whether starting gabapentin within 72 hours of rash onset could relieve acute shingles pain or prevent postherpetic neuralgia from developing. It found no benefit on either front. At 12 weeks, 18.2% of patients in the gabapentin group still reported pain compared to 9.5% in the placebo group, a difference that was not statistically significant. The researchers concluded that adding gabapentin to standard antiviral treatment provided no meaningful relief from acute pain and did not prevent long-term nerve pain.
This is an important finding because some patients and even some providers assume that starting gabapentin early might head off chronic pain. The evidence does not support that approach.
How Well It Works for Postherpetic Neuralgia
Once postherpetic neuralgia has set in, gabapentin becomes a first-line treatment. A Cochrane review, the gold standard for summarizing clinical trial data, found that among patients taking gabapentin at doses above 1,200 mg per day, 32% experienced a 50% or greater reduction in pain. A moderately beneficial effect (at least 30% pain reduction) occurred in 46% of patients.
Those numbers are worth putting in context. A one-in-three chance of cutting your pain in half may not sound dramatic, but postherpetic neuralgia is notoriously difficult to treat, and many people with it describe constant burning, stabbing, or electric-shock sensations that interfere with sleep and daily life. For the patients who do respond well, gabapentin can be genuinely life-changing.
How It Reduces Nerve Pain
Gabapentin doesn’t work like a typical painkiller. Instead of blocking pain signals directly, it attaches to a specific part of calcium channels on nerve cells. These channels control how much of a chemical signal gets released between nerves. In postherpetic neuralgia, damaged nerves become overactive, firing pain signals when they shouldn’t. Gabapentin reduces the number of these channels available at nerve endings, which dials down the excess signaling. It also appears to interfere with the formation of new excitatory connections between nerves, a process that can make chronic pain worse over time.
What to Expect When Starting Gabapentin
Gabapentin is typically started at a low dose, around 300 mg per day, and increased gradually over several weeks. In clinical trials, patients were titrated up over four weeks in steps (900, 1,800, 2,400, and up to 3,600 mg per day, divided into three doses). This slow ramp-up is necessary because jumping to a full dose causes more side effects. It also means you shouldn’t expect immediate relief.
In one study of older adults with shingles-related nerve pain, pain scores began dropping by the end of the first week. The greatest improvement came at the end of the second week, with a plateau by weeks three and four. So while it’s not overnight, most people who will benefit from gabapentin start noticing a difference within the first two weeks of reaching an effective dose.
The most common side effects are drowsiness and dizziness, which are particularly relevant since shingles disproportionately affects older adults. These effects tend to be most noticeable during the dose increases and often improve as your body adjusts. Because gabapentin is cleared through the kidneys, people with reduced kidney function may need lower doses to avoid side effects from the drug building up in their system.
Gabapentin vs. Pregabalin
Pregabalin works through a very similar mechanism and is also approved for postherpetic neuralgia. A meta-analysis comparing the two found that pregabalin was somewhat better at reducing pain and improving sleep, but gabapentin had a lower rate of side effects and a better overall safety profile. The clinical differences between the two are modest enough that either one is considered a reasonable first choice. If one doesn’t work well or causes too many side effects, switching to the other is a common next step.
How Long Treatment Lasts
Postherpetic neuralgia sometimes resolves on its own over months, but it can also persist for years. There’s no fixed duration for gabapentin treatment. Most clinicians will reassess periodically, typically by gradually reducing the dose to see whether the underlying pain has improved. Stopping gabapentin abruptly can cause withdrawal symptoms, so any tapering should be done gradually. Some people take it for a few months, others for much longer, depending on whether the nerve damage continues to produce pain.